Neurocognitive function in relation to blood lead among young men prior to chronic occupational exposure.

Objectives Higher than contemporary exposure levels and advanced age of study participants have limited the interpretation of previous studies relating neurocognitive function to lead exposure. We reassessed this association in young American men prior to chronic occupational exposure at lead recycling plants, using baseline measurements of the Study for Promotion of Health in Recycling Lead (NCT02243904). Methods We administered the Stroop test (ST) and the digit-symbol test (DST) to 339 men (mean age, 28.6 years; participation rate 82.7%). Whole blood lead (BL) was determined by inductively coupled plasma mass spectrometry and related ST and DST test results using multivariable-adjusted regression. Results Average values were 4.26 μg/dL for BL, 1624 ms and 1474 ms for mean reaction time in incongruent and congruent ST trials, and 109 sec for mean total latency in DST. The number of participants with fully correct answers amounted to 281 (82.9%) and 334 (98.5%) in incongruent and congruent ST trials, respectively, and to 198 (58.4%) in the DST. In multivariable-adjusted analyses, there was no association between cognitive performance and BL except for a weak but opposite association in DST; for a 10-fold BL increment, mean total latency was 5.4% (95% confidence interval, -0.4‒11.5%; P=0.066) higher, whereas the error score was 42% (-10‒69%; P=0.096) lower. To exclude an effect of the cumulative lead dose, sensitivity analyses restricted to workers <40, 35 and 30 years were confirmatory. Conclusions At the exposure levels in our current study, we failed to demonstrate a consistent inverse association of BL with neurocognitive performance in young American men.

[1]  S. Studenski,et al.  Digit Symbol Substitution test and future clinical and subclinical disorders of cognition, mobility and mood in older adults. , 2016, Age and ageing.

[2]  Hao Wang,et al.  Lead decreases cell survival, proliferation, and neuronal differentiation of primary cultured adult neural precursor cells through activation of the JNK and p38 MAP kinases. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.

[3]  J. Staessen,et al.  Study for Promotion of Health in Recycling Lead – Rationale and design , 2015, Blood pressure.

[4]  Jingxia Li,et al.  Lead induces COX-2 expression in glial cells in a NFAT-dependent, AP-1/NFκB-independent manner. , 2014, Toxicology.

[5]  C. Sousa,et al.  Mitochondria are the main source and one of the targets of Pb (lead)-induced oxidative stress in the yeast Saccharomyces cerevisiae , 2014, Applied Microbiology and Biotechnology.

[6]  J. Schwartz,et al.  Lead exposure and rate of change in cognitive function in older women. , 2014, Environmental research.

[7]  K. Safranow,et al.  Disrupted pro- and antioxidative balance as a mechanism of neurotoxicity induced by perinatal exposure to lead , 2012, Brain Research.

[8]  D. Cory-Slechta,et al.  Blood lead levels in relation to cognitive function in older U.S. adults. , 2011, Neurotoxicology.

[9]  Howard Aizenstein,et al.  Executive control function, brain activation and white matter hyperintensities in older adults , 2010, NeuroImage.

[10]  M. Taira,et al.  Cortical areas related to performance of WAIS Digit Symbol Test: A functional imaging study , 2009, Neuroscience Letters.

[11]  E. Krieg,et al.  Blood lead, serum homocysteine, and neurobehavioral test performance in the third National Health and Nutrition Examination Survey. , 2009, Neurotoxicology.

[12]  J. Schwartz,et al.  Cumulative Exposure to Lead in Relation to Cognitive Function in Older Women , 2008, Environmental health perspectives.

[13]  Lucila Aimo,et al.  Aluminium and lead: molecular mechanisms of brain toxicity , 2008, Archives of Toxicology.

[14]  J. Staessen,et al.  Bone Resorption and Environmental Exposure to Cadmium in Women: A Population Study , 2008, Environmental health perspectives.

[15]  Hui Xu,et al.  Iron supplement prevents lead-induced disruption of the blood-brain barrier during rat development. , 2007, Toxicology and applied pharmacology.

[16]  A. Spiro,et al.  Cumulative Lead Exposure and Cognitive Performance Among Elderly Men , 2007, Epidemiology.

[17]  B. Schwartz,et al.  Cumulative Lead Dose and Cognitive Function in Adults: A Review of Studies That Measured Both Blood Lead and Bone Lead , 2006, Environmental health perspectives.

[18]  Brian S. Schwartz,et al.  The Epidemiology of Lead Toxicity in Adults: Measuring Dose and Consideration of Other Methodologic Issues , 2006, Environmental health perspectives.

[19]  H. Amièva,et al.  Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies. , 2006, American journal of epidemiology.

[20]  B S Schwartz,et al.  Environmental lead exposure and cognitive function in community-dwelling older adults , 2006, Neurology.

[21]  H. Rüdiger,et al.  No cognitive deficits in men formerly exposed to lead , 2005, Wiener klinische Wochenschrift.

[22]  E. Krieg,et al.  The Relationship between Blood Lead Levels and Neurobehavioral Test Performance in NHANES III and Related Occupational Studies , 2005, Public health reports.

[23]  Tobias Egner,et al.  The neural correlates and functional integration of cognitive control in a Stroop task , 2005, NeuroImage.

[24]  Gary F. Egan,et al.  Functional connectivity during Stroop task performance , 2005, NeuroImage.

[25]  J. Links,et al.  Occupational Lead Exposure and Longitudinal Decline in Neurobehavioral Test Scores , 2005, Epidemiology.

[26]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2004, Journal international de bioethique = International journal of bioethics.

[27]  A. Spiro,et al.  Lead Exposure Biomarkers and Mini-Mental Status Exam Scores in Older Men , 2003, Epidemiology.

[28]  J. Coresh,et al.  Blood lead and chronic kidney disease in the general United States population: results from NHANES III. , 2003, Kidney international.

[29]  H. Rüdiger,et al.  Reduced cognitive abilities in lead-exposed men , 2002, International archives of occupational and environmental health.

[30]  W. Stewart,et al.  Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with neurobehavioral test scores in South Korean lead workers. , 2001, American journal of epidemiology.

[31]  A. Spiro,et al.  Relations of bone and blood lead to cognitive function: the VA Normative Aging Study. , 1998, Neurotoxicology and teratology.

[32]  M. Bleecker,et al.  Differential contribution of current and cumulative indices of lead dose to neuropsychological performance by age , 1997, Neurology.

[33]  K. Flegal,et al.  The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES) , 1994, JAMA.

[34]  D. Cory-Slechta,et al.  Homogeneity of regional brain lead concentrations. , 1994, Neurotoxicology.

[35]  M. Elseviers,et al.  Healthy worker effect in a cross-sectional study of lead workers. , 1993, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[36]  M. Rabinowitz,et al.  Toxicokinetics of bone lead. , 1991, Environmental health perspectives.

[37]  J. Staessen,et al.  Health effects of environmental exposure to cadmium: objectives, design and organization of the cadmibel study: a cross-sectional morbidity study carried out in Belgium from 1985 to 1989 , 1990, Environmental health perspectives.

[38]  P. Gartside The relationship of blood lead levels and blood pressure in NHANES II: additional calculations. , 1988, Environmental health perspectives.

[39]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[40]  T. Ikeda,et al.  Regional distribution of lead, zinc, iron and copper in suckling and adult rat brains , 1982, Brain Research.

[41]  J O Westgard,et al.  A multi-rule Shewhart chart for quality control in clinical chemistry. , 1981, Clinical chemistry.

[42]  P. Grandjean Regional distribution of lead in human brains , 1978 .